🇺🇸 FDA
Pipeline program

Pemetrexed and Reolysin (and safety run-in)

I211

Phase 2 small_molecule completed

Quick answer

Pemetrexed and Reolysin (and safety run-in) for Non Small Cell Lung Cancer is a Phase 2 program (small_molecule) at ONCOLYTICS BIOTECH INC with 1 ClinicalTrials.gov record(s).

Program details

Company
ONCOLYTICS BIOTECH INC
Indication
Non Small Cell Lung Cancer
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials